From Forest to Pharma: Profiling Fungal Strains for Lovastatin Production in Cardiovascular Disease Management

Abstract Background Fungal statins such as lovastatin are vital cholesterol-lowering drugs for cardiovascular disease (CVD). Novel fungal producers remain underexplored. This study screened forest soil fungi for lovastatin production and optimized culture conditions. Methods Twenty-one isolates were tested for lovastatin activity by yeast inhibition assays. Active strains underwent submerged fermentation under varying carbon sources (sucrose, maltose, lactose, mannitol, dextrose), pH (4–8), and temperature (20–40 °C). Lovastatin levels in extracts were quantified by HPLC. Top producers were identified by ITS rDNA sequencing. Results Five isolates (C1, C2, C3, D2, E1) inhibited S. cerevisiae but not C. albicans. These produced lovastatin equivalents under fermentation. The highest yield was by isolate C3 (41.6% lovastatin-equivalent) on mannitol; C1 and C2 also favored mannitol, while E1 yielded most on maltose. Low pH (4–5) abolished production; optimal output occurred at pH 6–8. No statin was made at 35–40 °C; each strain peaked at 20–30 °C. ITS sequencing identified the active isolates as Aspergillus spp. related to A. austwickii/aflatoxiformans. Conclusion Forest-derived Aspergillus strains can biosynthesize lovastatin, with yields highly dependent on culture conditions. The discovery of these lovastatin-producing fungi highlights a novel natural source for statins in CVD therapy. Further strain improvement and process optimization could enable sustainable production of fungal statins for cardiovascular health.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-17
DOI
https://doi.org/10.21203/rs.3.rs-7761154/v1
Primary Topic
Microbial Natural Products and Biosynthesis
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

From Forest to Pharma: Profiling Fungal Strains for Lovastatin Production in Cardiovascular Disease Management

Abdulaziz Asiri, Shadma Siddiqui
Research Square
Microbial Natural Products and Biosynthesis
preprint

From Forest to Pharma: Profiling Fungal Strains for Lovastatin Production in Cardiovascular Disease Management

Abdulaziz Asiri, Shadma Siddiqui
preprint en

Abstract

Abstract Background Fungal statins such as lovastatin are vital cholesterol-lowering drugs for cardiovascular disease (CVD). Novel fungal producers remain underexplored. This study screened forest soil fungi for lovastatin production and optimized culture conditions. Methods Twenty-one isolates were tested for lovastatin activity by yeast inhibition assays. Active strains underwent submerged fermentation under varying carbon sources (sucrose, maltose, lactose, mannitol, dextrose), pH (4–8), and temperature (20–40 °C). Lovastatin levels in extracts were quantified by HPLC. Top producers were identified by ITS rDNA sequencing. Results Five isolates (C1, C2, C3, D2, E1) inhibited S. cerevisiae but not C. albicans. These produced lovastatin equivalents under fermentation. The highest yield was by isolate C3 (41.6% lovastatin-equivalent) on mannitol; C1 and C2 also favored mannitol, while E1 yielded most on maltose. Low pH (4–5) abolished production; optimal output occurred at pH 6–8. No statin was made at 35–40 °C; each strain peaked at 20–30 °C. ITS sequencing identified the active isolates as Aspergillus spp. related to A. austwickii/aflatoxiformans. Conclusion Forest-derived Aspergillus strains can biosynthesize lovastatin, with yields highly dependent on culture conditions. The discovery of these lovastatin-producing fungi highlights a novel natural source for statins in CVD therapy. Further strain improvement and process optimization could enable sustainable production of fungal statins for cardiovascular health.

Research Square
University of Bisha (SA)
Good health and well-being
Microbial Natural Products and Biosynthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon